References:
1. Roy U, Panwar A, Pandit A, Das SK, Joshi BJJoc, JCDR dr. Clinical and neuroradiological spectrum of metronidazole induced encephalopathy: our experience and the review of literature. 2016;10(6):OE01.
2. Bradley WG, Karlsson I, Rassol CJBmj. Metronidazole neuropathy. 1977;2(6087):610.
3. De Bleecker JL, Leroy BP, Meire VIJEn. Reversible visual deficit and corpus callosum lesions due to metronidazole toxicity. 2005;53(2):93-95.
4. Huang Y-T, Chen L-A, Cheng S-JJANT. Metronidazole-induced encephalopathy: case report and review literature. 2012;21(2):74-78.
5. Kuriyama A, Jackson JL, Doi A, Kamiya TJCn. Metronidazole-induced central nervous system toxicity: a systematic review. 2011;34(6):241-247.
6. Sørensen CG, Karlsson WK, Amin FM, Lindelof MJJon. Metronidazole-induced encephalopathy: a systematic review. 2020;267(1):1-13.
7. Eren F, Aldan MA, Dogan VB, Gül G, Selcuk HH, Soysal AJIs. A case with reversible neurotoxicity induced by metronidazole. 2017;70(11-12):429-432.
8. Singh R, Kaur R, Pokhariyal P, Aggarwal RJTIjor, imaging. Sequential MR imaging (with diffusion-weighted imaging) changes in metronidazole-induced encephalopathy. 2017;27(2):129.
9. Foreid H, Coelho M, Ferreira J, Ferro JMJCR. Reversible iatrogenic subacute cerebellar syndrome, myoclonus and MRI findings following metronidazole administration. 2009;2009:bcr0520091841.
10. Galvez M, Brahm J, Miranda MJMD. Movement disorders as a manifestation of metronidazole‐induced encephalopathy in a patient with chronic liver disease. 2009;24(12):1864-1866.
11. Jafari G, Hosseini SM, Akhondzadeh SJDJoPS. Sudden hearing loss subsequent to diarrhea: what is the missing link? 2014;22(1):15.
12. Haghighi-Morad M, Naseri Z, Jamshidi N, Hassanian-Moghaddam H, Zamani N, Ahmad-Molaei LJBMI. Methadone-induced encephalopathy: a case series and literature review. 2020;20(1):6.